Chlamydia pneumoniae in community-acquired pneumonia: seven years of experience

J Infect. 2002 Oct;45(3):135-8. doi: 10.1016/s0163-4453(02)91036-4.

Abstract

Objectives: To determine the prevalence of Chlamydia pneumoniae in community-acquired pneumonia during a period of seven years.

Methods: Serum samples from 311 patients with pneumonia were evaluated using microimmunofluorescence assay to detect C. pneumoniae -specific IgG and IgM antibodies.

Results: Thirty nine patients (12.5%) complied with the diagnostic criteria of acute C. pneumoniae infection (a four-fold rise in the titer of IgG antibody, or a single IgG titer > or = 1:512, or a single IgM titer > or = 1:16). All patients were diagnosed as having pneumonia. Co-infection with other respiratory tract pathogens was found in four patients.

Conclusions: C. pneumoniae is an important cause of pneumonia also in our area. Pneumonia due to this bacterium occurs in the cold months and in early spring; in addition we have observed periods of increased incidence of one years duration and periods of low incidence lasting one-two years. Therapy with macrolides and levofloxacin was effective in all patients with C. pneumoniae infection.

MeSH terms

  • Anti-Bacterial Agents / classification
  • Anti-Bacterial Agents / therapeutic use
  • Chlamydophila Infections / epidemiology*
  • Chlamydophila Infections / microbiology
  • Chlamydophila pneumoniae* / immunology
  • Chlamydophila pneumoniae* / pathogenicity
  • Community-Acquired Infections / diagnosis
  • Community-Acquired Infections / epidemiology
  • Community-Acquired Infections / prevention & control
  • Female
  • Humans
  • Immunoglobulin G / immunology
  • Immunoglobulin M / immunology
  • Incidence
  • Male
  • Prevalence
  • Prospective Studies
  • Risk Factors
  • Serologic Tests

Substances

  • Anti-Bacterial Agents
  • Immunoglobulin G
  • Immunoglobulin M